{
  "id": 196740,
  "name": "CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP",
  "slug": "conafay-group-on-behalf-of-antibiotics-working-group",
  "state": "NC",
  "description": "Representing the voice of emerging antibiotics industry",
  "totalSpending": 1600000,
  "filings": 26,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 240000
    },
    {
      "year": 2019,
      "income": 270000
    },
    {
      "year": 2020,
      "income": 210000
    },
    {
      "year": 2021,
      "income": 280000
    },
    {
      "year": 2022,
      "income": 280000
    },
    {
      "year": 2023,
      "income": 170000
    },
    {
      "year": 2024,
      "income": 10000
    },
    {
      "year": 2025,
      "income": 140000
    }
  ],
  "firms": [
    "THE CONAFAY GROUP, LLC"
  ],
  "lobbyists": [
    "WILLIAM FRANCO",
    "STEPHEN CONAFAY",
    "EMILY WHEELER",
    "DARIN GARDNER",
    "JOSH NARROW",
    "BRYAN SHUY"
  ],
  "issues": [
    "HCR",
    null
  ],
  "sampleDescriptions": [
    "Legislation related to DISARM and R&D tax credit.",
    "Legislation related to DISARM and R&D tax credit and biologics.",
    "Legislation related to antimicrobial resistance(AMR), the DISARM Act, the PASTEUR Act, Cures 2.0 and COVID19 response packages.",
    "Legislation related to antimicrobial resistance(AMR), the DISARM Act, the PASTEUR Act, Cares Act 2.0 and COVID19 response packages.",
    "Legislation related to antimicrobial resistance(AMR), reimbursement reform, the PASTEUR Act, Cares Act 2.0 and FY24 Appropriations and PAHPA.",
    "Legislation related to antimicrobial resistance(AMR), reimbursement reform, the PASTEUR Act, Cares Act 2.0 and FY25 Appropriations and PAHPA.",
    "Legislation related to antimicrobial resistance(AMR), reimbursement reform, CURES Act 2.0 and FY25 Appropriations and PAHPA.",
    "Legislation related to antimicrobial resistance(AMR), reimbursement reform, CURES Act 2.0 and FY26 Appropriations and PAHPA."
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": -42,
  "trajectory": "reducing",
  "yearsActive": 8,
  "avgAnnualSpending": 200000,
  "peakYear": 2021,
  "lobbyistCount": 6,
  "firmCount": 1,
  "issueCount": 1
}